Form 4: AdaptHealth Director David S. Williams III Increases Stake with Significant Share Acquisition

AdaptHealth Corp. Director David S. Williams III acquired 21,346 shares of common stock, increasing his beneficial ownership to 58,245 shares, as reported in a recent SEC Form 4 filing.

Summary

• David Solomon Williams III, a Director of AdaptHealth Corp. (AHCO), acquired 21,346 shares of common stock.
• The transaction occurred on June 26, 2025.
• The shares were acquired at a price of $0 per share, indicating a grant or award rather than an open market purchase.
• Following this transaction, David S. Williams III beneficially owns a total of 58,245 shares of AdaptHealth Corp. common stock.
• The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if a grant, generally indicates continued alignment of interests and can be viewed positively as it increases insider ownership. The Power of Attorney is a standard legal document.

Positives

• A director increasing their beneficial ownership, even through a grant, can signal continued alignment with shareholder interests and confidence in the company's future.

Negatives

• The acquisition price of $0 suggests the shares were granted, likely as part of compensation or a vesting schedule, rather than purchased on the open market, which would typically indicate a direct cash investment by the director.

Risks

• The Power of Attorney explicitly states that neither the Company nor the Attorneys-in-Fact assume any liability for the undersigned's responsibility to comply with Section 13 or Section 16 of the Exchange Act or Rule 144, any liability for failure to comply, or any liability for disgorgement of profits under Section 16(b) of the Exchange Act.
• The Power of Attorney also notes that it does not relieve the undersigned from responsibility for compliance with their obligations under Section 13 or Section 16 of the Exchange Act.

Future Outlook

NA

Management Comments

• This Power of Attorney authorizes, but does not require, each Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information.
• Any documents prepared or executed by either Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as such Attorney-in-Fact, in his or her discretion, deems necessary or desirable.
• Neither the Company nor the Attorneys-in-Fact assume any liability for the undersigned's responsibility to comply with the requirements of Section 13 or Section 16 of the Exchange Act or Rule 144, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act.
• This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 13 or Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 13 or Section 16 of the Exchange Act.

Industry Context

This filing is a routine insider transaction report for a healthcare company, specifically in the home medical equipment and supplies sector. Such filings are common across all industries and reflect individual executive or director stock movements rather than broad industry trends.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased insider ownership may be viewed positively as it aligns the director's interests with those of shareholders.
• Management/Employees: The grant of shares is part of the compensation structure for directors, which is a standard practice.

Next Steps

• The Power of Attorney remains in effect until the undersigned is no longer required to file Forms 4 or 5 or Schedules 13D or 13G or Forms 144 with respect to their holdings and transactions in company securities, unless earlier revoked.

Key Dates

Recommendation

Keywords

AdaptHealth Corp., AHCO, Form 4, Insider Trading, Director Share Acquisition, Beneficial Ownership, Equity Grant, SEC Filing, David S. Williams III, Corporate Governance